Skip to content

In the BioHarmony Drug Report Database

Arsenic trioxide

Trisenox (arsenic trioxide) is a small molecule pharmaceutical. Arsenic trioxide was first approved as Trisenox on 2000-09-25. It is used to treat promyelocytic leukemia acute in the USA. It has been approved in Europe to treat promyelocytic leukemia acute.
Trade Name Trisenox
Common Name Arsenic trioxide
Indication promyelocytic leukemia acute
Drug Class Antineoplastic agent
Arsenic trioxide
Get full access now